Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease

Jamie L. Russell, Sean C. Goetsch, Hector R. Aguilar, Helen Coe, Xiang Luo, Ning Liu, Eva Van Rooij, Doug E. Frantz, Jay W. Schneider

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Chemical biology promises discovery of new and unexpected mechanistic pathways, protein functions and disease targets. Here, we probed the mechanism-of-action and protein targets of 3,5-disubstituted isoxazoles (Isx), cardiomyogenic small molecules that target Notch-activated epicardium-derived cells (NECs) in vivo and promote functional recovery after myocardial infarction (MI). Mechanistic studies in NECs led to an Isx-activated G q protein-coupled receptor (G qPCR) hypothesis tested in a cell-based functional target screen for GPCRs regulated by Isx. This screen identified one agonist hit, the extracellular proton/pH-sensing GPCR GPR68, confirmed through genetic gain- and loss-of-function. Overlooked until now, GPR68 expression and localization were highly regulated in early post-natal and adult post-infarct mouse heart, where GPR68-expressing cells accumulated subepicardially. Remarkably, GPR68-expressing cardiomyocytes established a proton-sensing cellular "buffer zone" surrounding the MI. Isx pharmacologically regulated gene expression (mRNAs and miRs) in this GPR68-enriched border zone, driving cardiomyogenic and pro-survival transcriptional programs in vivo. In conclusion, we tracked a (micromolar) bioactive small molecules mechanism-of-action to a candidate target protein, GPR68, and validated this target as a previously unrecognized regulator of myocardial cellular responses to tissue acidosis, setting the stage for future (nanomolar) target-based drug lead discovery.

Original languageEnglish (US)
Pages (from-to)1077-1083
Number of pages7
JournalACS Chemical Biology
Volume7
Issue number6
DOIs
StatePublished - Jun 15 2012

Fingerprint

Isoxazoles
Myocardial Ischemia
Pericardium
Pharmaceutical Preparations
Protons
Proteins
Myocardial Infarction
Molecules
Drug Discovery
G-Protein-Coupled Receptors
Acidosis
Cardiac Myocytes
Gene expression
Buffers
Tissue
Gene Expression
Recovery
Messenger RNA
human GPR68 protein

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. / Russell, Jamie L.; Goetsch, Sean C.; Aguilar, Hector R.; Coe, Helen; Luo, Xiang; Liu, Ning; Van Rooij, Eva; Frantz, Doug E.; Schneider, Jay W.

In: ACS Chemical Biology, Vol. 7, No. 6, 15.06.2012, p. 1077-1083.

Research output: Contribution to journalArticle

@article{863228515a094ccbbe74e6f958f8e690,
title = "Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease",
abstract = "Chemical biology promises discovery of new and unexpected mechanistic pathways, protein functions and disease targets. Here, we probed the mechanism-of-action and protein targets of 3,5-disubstituted isoxazoles (Isx), cardiomyogenic small molecules that target Notch-activated epicardium-derived cells (NECs) in vivo and promote functional recovery after myocardial infarction (MI). Mechanistic studies in NECs led to an Isx-activated G q protein-coupled receptor (G qPCR) hypothesis tested in a cell-based functional target screen for GPCRs regulated by Isx. This screen identified one agonist hit, the extracellular proton/pH-sensing GPCR GPR68, confirmed through genetic gain- and loss-of-function. Overlooked until now, GPR68 expression and localization were highly regulated in early post-natal and adult post-infarct mouse heart, where GPR68-expressing cells accumulated subepicardially. Remarkably, GPR68-expressing cardiomyocytes established a proton-sensing cellular {"}buffer zone{"} surrounding the MI. Isx pharmacologically regulated gene expression (mRNAs and miRs) in this GPR68-enriched border zone, driving cardiomyogenic and pro-survival transcriptional programs in vivo. In conclusion, we tracked a (micromolar) bioactive small molecules mechanism-of-action to a candidate target protein, GPR68, and validated this target as a previously unrecognized regulator of myocardial cellular responses to tissue acidosis, setting the stage for future (nanomolar) target-based drug lead discovery.",
author = "Russell, {Jamie L.} and Goetsch, {Sean C.} and Aguilar, {Hector R.} and Helen Coe and Xiang Luo and Ning Liu and {Van Rooij}, Eva and Frantz, {Doug E.} and Schneider, {Jay W.}",
year = "2012",
month = "6",
day = "15",
doi = "10.1021/cb300001m",
language = "English (US)",
volume = "7",
pages = "1077--1083",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease

AU - Russell, Jamie L.

AU - Goetsch, Sean C.

AU - Aguilar, Hector R.

AU - Coe, Helen

AU - Luo, Xiang

AU - Liu, Ning

AU - Van Rooij, Eva

AU - Frantz, Doug E.

AU - Schneider, Jay W.

PY - 2012/6/15

Y1 - 2012/6/15

N2 - Chemical biology promises discovery of new and unexpected mechanistic pathways, protein functions and disease targets. Here, we probed the mechanism-of-action and protein targets of 3,5-disubstituted isoxazoles (Isx), cardiomyogenic small molecules that target Notch-activated epicardium-derived cells (NECs) in vivo and promote functional recovery after myocardial infarction (MI). Mechanistic studies in NECs led to an Isx-activated G q protein-coupled receptor (G qPCR) hypothesis tested in a cell-based functional target screen for GPCRs regulated by Isx. This screen identified one agonist hit, the extracellular proton/pH-sensing GPCR GPR68, confirmed through genetic gain- and loss-of-function. Overlooked until now, GPR68 expression and localization were highly regulated in early post-natal and adult post-infarct mouse heart, where GPR68-expressing cells accumulated subepicardially. Remarkably, GPR68-expressing cardiomyocytes established a proton-sensing cellular "buffer zone" surrounding the MI. Isx pharmacologically regulated gene expression (mRNAs and miRs) in this GPR68-enriched border zone, driving cardiomyogenic and pro-survival transcriptional programs in vivo. In conclusion, we tracked a (micromolar) bioactive small molecules mechanism-of-action to a candidate target protein, GPR68, and validated this target as a previously unrecognized regulator of myocardial cellular responses to tissue acidosis, setting the stage for future (nanomolar) target-based drug lead discovery.

AB - Chemical biology promises discovery of new and unexpected mechanistic pathways, protein functions and disease targets. Here, we probed the mechanism-of-action and protein targets of 3,5-disubstituted isoxazoles (Isx), cardiomyogenic small molecules that target Notch-activated epicardium-derived cells (NECs) in vivo and promote functional recovery after myocardial infarction (MI). Mechanistic studies in NECs led to an Isx-activated G q protein-coupled receptor (G qPCR) hypothesis tested in a cell-based functional target screen for GPCRs regulated by Isx. This screen identified one agonist hit, the extracellular proton/pH-sensing GPCR GPR68, confirmed through genetic gain- and loss-of-function. Overlooked until now, GPR68 expression and localization were highly regulated in early post-natal and adult post-infarct mouse heart, where GPR68-expressing cells accumulated subepicardially. Remarkably, GPR68-expressing cardiomyocytes established a proton-sensing cellular "buffer zone" surrounding the MI. Isx pharmacologically regulated gene expression (mRNAs and miRs) in this GPR68-enriched border zone, driving cardiomyogenic and pro-survival transcriptional programs in vivo. In conclusion, we tracked a (micromolar) bioactive small molecules mechanism-of-action to a candidate target protein, GPR68, and validated this target as a previously unrecognized regulator of myocardial cellular responses to tissue acidosis, setting the stage for future (nanomolar) target-based drug lead discovery.

UR - http://www.scopus.com/inward/record.url?scp=84862552061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862552061&partnerID=8YFLogxK

U2 - 10.1021/cb300001m

DO - 10.1021/cb300001m

M3 - Article

VL - 7

SP - 1077

EP - 1083

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 6

ER -